Mizuho raises Encompass Health stock price target on strong demand
Mizuho raised its price target on Encompass Health (EHC) to $155 from $140, citing strong demand and increased EBITDA estimates. The stock is up 29% YTD. Other analysts also raised targets post Q3 results, which beat estimates. EHC reported $1.61B revenue and $1.52 EPS, raising its full-year outlook.
How this was made
The 30-second read
Why it matters
Analyst upgrades and higher price targets reflect confidence in the company's growth strategy and earnings momentum.
Market read
EHC's earnings beat and multiple analyst upgrades provide a fresh bullish catalyst for the stock.
What to watch
Potential headwinds from payer reimbursement policies could limit growth.
Background
Encompass Health (EHC) provides inpatient rehabilitation services and reported Q3 revenue of $1.61 bn, beating estimates.
Ticker impact
Mizuho raised its price target on Encompass Health to $155 after the company reported strong third‑quarter earnings.
likely upward pressure as investors price in higher target and earnings beat
Target raise follows earnings beat and higher EBITDA guidance, providing a clear catalyst.
Market effects
Strong rehab demand may benefit the broader post‑acute care sector.
U.S. healthcare stocks could see modest gains.
Limited to U.S. healthcare investors.
Counterpoint
If the earnings beat is already priced in, the target raise may not translate into further upside.
Key entities
- analystMizuho
Raised price target to $155 and maintained Outperform rating.
- analystRaymond James
Raised price target to $155 after earnings beat.
